KWF/TKI-LSH funding for innovative SureTACs technology

SureTACs (Surface Removal Targeting Chimeras) are heterobispecific molecules that target undesired cell surface proteins for degradation. The project is a collaboration of our lab at UMCU with Oncode and Laigo Bio.

Oncode Investigator @MadelonMaurice (@UMCUtrecht) received funding from @kwf_nl and @HealthHolland to further study the innovative SureTAC technology, designed in collaboration with @argobio and Oncode to break down cancer-specific proteins. Read more: https://t.co/UVV2qtfFTY pic.twitter.com/dUCKSoOpDY
— Oncode Institute (@oncodeinstitute) July 28, 2022

https://www.umcutrecht.nl/nl/over-ons/nieuws/algemeen/grote-subsidies-voor-publiek-privaat-kankeronderzoek

https://www.oncode.nl/news/oncode-investigator-madelon-maurice-receives-kwf-funding-for-innovative-suretac-technology

https://www.kwf.nl/onderzoek/dit-onderzoek-maken-we-mogelijk/PPS-toekenningen-2022-1

Share this:

Leave a Reply Cancel reply